Chris McClellan
Story Poster
Key Matchups: No. 3 Texas A&M at No. 22 Missouri
21 days ago by Olin Buchanan
The 8-0 Fightin' Texas Aggies will put their unbeaten record on the line against No. 22 Missouri on Saturday afternoon. Ahead of the road trip to Columbia, Olin Buchanan details the in-game matchups that will have the greatest impact on the outcome.
Story Poster
Tale of the Tape: No. 3 Texas A&M at No. 22 Missouri
23 days ago by TexAgs
While Texas A&M vs. Missouri is not a rivalry, perhaps this weekend's top-25 showdown in Columbia will have a little extra juice following the antics surrounding last year's matchup at Kyle Field as the No. 3 vs. No. 22 matchup has big-time playoff implications.
Story Poster
Mizzou embraces the challenges of aiming for another 10-win season
6 mo ago by Olin Buchanan
Missouri football is chasing a pattern that has never been accomplished in Columbia as the Tigers seek their third consecutive 10-win season after winning 11 in 2023 and 10 in 2024, but with so many key pieces to replace, such a goal won't come easy for Eli Drinkwitz & Co.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Tale of the Tape: No. 25 Texas A&M vs. No. 9 Missouri
1 yr ago by TexAgs
Despite having a 4-0 record, Eli Drinkwitz and the ninth-ranked Missouri Tigers come to Kyle Field with a lot to prove as Mike Elko's No. 25 Aggies look to extend their winning streak to five straight. The top-25 showdown in Aggieland is the only ranked vs. ranked matchup in Week 6.
Story Poster
Billy Napier's success in Gainesville may rely on fast start to 2022 season
3 yr ago by Olin Buchanan
Coming off their first losing season since 2017, Florida remains optimistic as Billy Napier takes control of the program. Yet, a fast start may be the key to sustained success in Gainesville as a number of previous head coaches succumbed to the same pressure Napier now faces.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.